Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Commodities And Pharma Push FTSE 100 Below 6,000

Tue, 22nd Sep 2015 16:11

LONDON (Alliance News) - Stocks in London ended down Tuesday, with commodities-related stocks and pharmaceutical shares dragging down the FTSE 100, which ended below the 6,000 line for the first time in nearly a month.

The blue-chip index closed down 2.8% at 5,935.84 points, with all its constituents in the red except for RSA Insurance, which ended up 0.6%, a day after its shares tumbled 21% because Zurich Insurance pulled out of talks to buy the company.

The mid-cap FTSE 250 index declined 2.2% to 16,529.98, while the AIM All-Share ended down 1.3% at 730.51. European major indices also finished lower, with the CAC 40 in Paris down 3.4% and the DAX 30 in Frankfurt off 3.8%.

Shares in China closed higher as the Hang Seng index ended up 0.2% and the Shanghai Composite up 0.9%, while the Japanese market remained closed for holiday until Thursday.

In the US, stocks were in the red at the London close. The Dow Jones Industrial Average was down 1.7%, the S&P 500 down 1.7% and the Nasdaq Composite down 2.1%.

The strength of the dollar since the US Federal Reserve on Thursday last week decided to keep US interest rates on hold is hurting the price of commodities such as gold, silver and oil. The yellow metal retreated Tuesday to USD1,125.72 an ounce, while silver was down at USD14.79 per ounce.

The pound was lower against the dollar Tuesday at the London close, standing at USD1.5366, having traded at USD1.5558 before the Fed decision last week.

As a result, London-listed mining and oil-related stocks took yet another hit on Tuesday, with miners' misery exacerbated by a series of downgrades in the sector by Credit Suisse.

Antofagasta, down 6.6%, was cut to Underperform from Neutral, while Anglo American, 6.1%, was downgraded to Neutral from Outperform. Mid-cap KAZ Minerals, down 25%, was cut to Neutral from Outperform.

Others such as BHP Billiton, down 4.2%, and Rio Tinto, down 3.5%, also ended among the biggest fallers. Glencore was the worst performer in the FTSE 100, down 9.6% at 107.53 pence, having touched a new all-time low of 99.59p, the first time its price has gone below 100.00p.

Oil also was under pressure Tuesday. At the London close, Brent oil prices were down at USD47.85 a barrel, coming off the level of USD50.31 prior to the Fed announcement, while West Texas Intermediate stood at USD45.62 a barrel, having traded at USD47.68 before the Fed decision.

Oil stocks finished lower, with BG Group down 3.0%, Royal Dutch Shell 'B' shares down 3.1% and BP down 2.5%.

Outside of the commodities sector, London-listed pharmaceutical companies were out of favour after US presidential candidate Hillary Clinton tweeted about "price gouging" in the specialty drug market.

On her official Twitter account Monday, Clinton cited a New York Times article which said the price of the Daraprim drug, which treats a life-threatening parasitic infection, soared to USD750 a tablet from USD13.50 a tablet overnight.

Clinton, the frontrunner for the Democratic nomination, tweeted "price gouging like this in the specialty drug market is outrageous. Tomorrow I'll lay out a plan to take it on". Clinton was scheduled to make the announcement in Des Moines, Iowa, at 2 pm local time Tuesday, which is 2000 BST.

Shire ended down 5.0%, AstraZeneca down 4.4% and GlaxoSmithKline down 3.1%. The FTSE 100 drug makers all have significant US sales.

Engineering company GKN also was amongst the biggest fallers, down 6.1%, amid worries about knock-on effects of the emissions cheating scandal engulfing German car maker Volkswagen, the largest customer of GKN's Driveline business.

Though UBS said that the impact on GKN is likely to be "trivial", shares in the engineer touched a low it hasn't seen since early 2013.

Meanwhile, Johnson Matthey, the platinum group metals company that makes emission control technologies, lost 8.0%

Supermarket chain J Sainsbury ended down 1.6% even though Kantar Worldpanel's grocery market survey said that it was the only big four UK supermarket to increase sales in the past 12 weeks, for the second consecutive period.

Sainsbury's sales rose 0.9% in the 12 weeks to September 13 to GBP4.01 billion from GBP3.97 billion in the same period a year earlier, as its market share stayed flat at 16.2%.

Sainsbury's blue-chip peers, whose sales Kantar said were lower, ended heavily in the red, with Tesco and Wm Morrison Supermarkets down 4.3% and 4.5%, respectively.

In the FTSE 250, IG Group Holdings led the mid-cap gainers, up 2.6% after it said its revenue increased substantially in the first quarter against a weak comparative, but said the volatile market conditions make it difficult to predict an outcome for the full year.

The spread betting and contracts-for-difference company, which gives retail traders access to financial markets, said it is trading in line with its expectations at present, with revenue in the first quarter to the end of August up 24% to GBP106.0 million, though it noted the same period last year was "particularly subdued".

Meanwhile, US-focused science and technology development and commercialisation company Allied Minds ended down 15%. Its shares dropped after New York-based hedge fund Kerrisdale Capital outlined the reasons for its short position in the London stock.

Kerrisdale said Allied Minds has "no objective evidence of commercial success" in its portfolio and said its review of the company's subsidiaries "indicates that they are developing products that are, at best, minor variations on existing alternatives, often in the face of significant competition and without plausible business models."

In the corporate calendar Wednesday, Smiths Group releases full-year results, United Utilities issues a trading statement, and Gresham House publishes half-year results. Meanwhile, Pan African Resources releases full-year results, while Highland Gold Mining and Styles&Wood Group publish half-year results.

In the economic calendar, China's Caixin manufacturing Purchasing Manager's Index is due at 0245 BST. Germany's manufacturing and services PMI are expected at 0830 BST, while the same for the eurozone are due at 0900 BST. European Central Bank President Mario Draghi speaks at the European Parliament in Brussels at 1400 BST.

In the US, Markit manufacturing PMI is due at 1445 BST, while Energy Information Administration crude oil stocks are at 1530 BST. Atlanta Federal Reserve President Dennis Lockhart speaks at 1730 BST before the Columbus Rotary Club in the state of Georgia.

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.